ARTICLE
3 December 2019

Opioid Cases Scheduled For Trial In New York

CC
Clyde & Co

Contributor

Clyde & Co  logo
Clyde & Co is a leading, sector-focused global law firm with 415 partners, 2200 legal professionals and 3800 staff in over 50 offices and associated offices on six continents. The firm specialises in the sectors that move, build and power our connected world and the insurance that underpins it, namely: transport, infrastructure, energy, trade & commodities and insurance. With a strong focus on developed and emerging markets, the firm is one of the fastest growing law firms in the world with ambitious plans for further growth.
A New York State case against manufacturers of opioid products has been scheduled for trial in March 2020.
United States Food, Drugs, Healthcare, Life Sciences

A New York State case against manufacturers of opioid products has been scheduled for trial in March 2020.

A New York State case against manufacturers of opioid products has been scheduled for trial in March 2020. The plaintiffs in the case are the State of New York and several counties who are suing pharmaceutical companies to recoup costs associated with treatment of state residents affected by the opioid epidemic. The trial will proceed on the plaintiffs' claims of public nuisance, deceptive business practices, false advertising, controlled substance act, repeated and persistent illegality, unjust enrichment, and negligence. A copy of the party-correspondence regarding the trial can be downloaded below.

Download PDF (565 KB)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More